Clozapine-Induced Neuroleptic Malignant Syndrome in an Adolescent

Ananth J , Parameswaran S , Gunatilake S , Burgoyne K , Sidhom T . Neuroleptic malignant syndrome and atypical antipsychotic drugs. J Clin Psychiatry, 65:464–470. 2004.

Caroff SN , Mann SC . Neuroleptic malignant syndrome. Med Clin North Am, 77:185–202. 1993.

Caroff SN , Mann SC , Campbell EC . Atypical antipsychotics and neuroleptic malignant syndrome. Psychiatr Ann, 30:314–321. 2000.

Croarkin PE , Emslie GJ , Mayes TL . Neuroleptic malignant syndrome associated with atypical antipsychotics in pediatric patients: A review of published cases. J Clin Psychiatry, 69:1157–1165. 2008.

Delay J , Deniker P . Drug-induced extrapyramidal syndromes. Handbook of Clinical Neurology: Diseases of the Basal Ganglia, 6 Vinken PJ , Bruyn GW . New York: Elsevier/North Holland, 1968; 248–266.

DelBello M , Grcevich S . Phenomenology and epidemiology of childhood psychiatric disorders that may necessitate treatment with atypical antipsychotics. J Clin Psychiatry, 65:12–19. 2004.

Findling RL , Steiner H , Weller EB . Use of antipsychotics in children and adolescents. J Clin Psychiatry, 66:29–40. 2005.

Guerrero RM , Shifrar KA . Diagnosis and treatment of neuroleptic malignant syndrome. Clin Pharm, 7:697–701. 1988.

Henderson T . Neuroleptic malignant syndrome in adolescents: Four probable cases in the Western Cape. S Afr Med J, 101:405–407. 2011.

Henderson VW , Wooten GF . Neuroleptic malignant syndrome: A pathogenetic role for dopamine receptor blockade? Neurology, 31:132. 1981.

Leucht S , Kissling W , McGrath J . Lithium for schizophrenia. Cochrane Database Syst Rev, 18:CD003834. 2007.

Levenson JL . Neuroleptic malignant syndrome. Am J Psychiatry, 142:1137–1145. 1985.

McClellan J , Kowatch R , Findling RL . Work Group on Quality Issues: Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry, 46:107–125. 2007.

McEvoy JP , Lieberman JA , Stroup TS , Davis SM , Meltzer HY , Rosenheck RA , Swartz MS , Perkins DO , Keefe RS , Davis CE , Severe J , Hsiao JK . Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. Am J Psychiatry, 16:600–610. 2006.

Neuhut R , Lindenmayer J , Silva R . Neuroleptic malignant syndrome in children and adolescents on atypical antipsychotic medication: A review. J Child Adolesc Psychopharmacol, 19:415–422. 2009.

Patel NC , Crimson ML , Hoagwood K , Johnsrud MT , Rascati KL , Wilson JP , Jensen PS . Trends in the use of typical and atypical antipsychotics in children and adolescents. J Am Acad Child Adolesc Psychiatry, 44:548–556. 2005.

Rosebush PI , Stewart TD , Gelenberg AJ . Twenty neuroleptic rechallenges after neuroleptic malignant syndrome in 15 patients. J Clin Psychiatry, 50:295–298. 1989.

Sachdev P , Kruk J , Kneebone M , Kissane D . Clozapine-induced neuroleptic malignant syndrome: Review and report of new cases. J Clin Psychopharmacol, 15:365–371. 1995.

Skarpathiotakis M , Westreich N . NMS after clozapine initiation (Letter) J Am Acad Child Adolesc Psychiatry, 44:1101–1102. 2005.

Silva RR , Munoz DM , Alpert M , Perlmutter IR , Diaz J . Neuroleptic malignant syndrome in children and adolescents. J Am Acad Child Adolesc, 38:187–194. 1999.

Stahl SM . Antipsychotic Agents. Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. Stahl SM Third Edition. New York: Cambridge University PressNY2008; 419–420.

Strawn JR , Keck PE , Caroff SN . Neuroleptic malignant syndrome. Am J Psychiatry, 164:870–876. 2007.

Trollor JN , Chen X , Sachdev PS . Neuroleptic malignant syndrome associated with atypical antipsychotic drugs. CNS Drugs, 23:477–492. 2009.